What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2.9% in the morning session ...

Genomics company Pacific Biosciences of California (NASDAQ:PACB) rose by 6.1% on Wednesday after Cathie Wood's investment ...

MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be ...

As of Wednesday, December 31, Pacific Biosciences of California, Inc.’s PACB share price has surged by 5.49%, which has ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued focus on research and development. The optimism, led by decent second-quarter 2024 earnings ...

PacBio's financials for 2023 show significant growth, with revenue more than doubling in Q4 and a 56% increase in annual revenue compared to the previous year. The company's product innovations, such ...

(RTTNews) - PacBio (PACB), a developer of highly accurate sequencing solutions, is slated to participate in several upcoming investor conferences this month, underscoring its visibility within the ...

(Reuters) - Gene-sequencing company Pacific BioSciences of California Inc on Tuesday announced the launch of a new, more affordable, higher-throughput "long-read" sequencer as well as customer testing ...

PacBio CEO Christian Henry speaks on day one of the in-person meeting of American Society of Human Genetics, the first in-person since 2019 Menlo Park-based Pacific Biosciences (PacBio) kicked off the ...

Pacific Biosciences raised the curtain on two DNA sequencers: its first short-read device, designed to offer new competition to the industry giant Illumina, as well as a machine poised to be an ...

Pacific Biosciences, a Menlo Park, Calif., firm best known for its niche approach to DNA sequencing, on Tuesday announced plans to launch a new product that will put the company in direct competition ...